Innova expands to double Cambridge footprint
Cambridge life science business Innova Biosciences, which provides bioconjugation products and services, has expanded its UK footprint to enable the company to increase its laboratory space.
Innova’s sales and marketing teams have moved from the Babraham Research Park to Ashwell Point in Sawston, accommodating another 2,500 sq ft of office space to double the company’s footprint across the two sites.
The move enables both extra laboratory and office space to allow for further growth as the company continues to expand. Innova claims to be a world leader in easy-to-use, cutting-edge bioconjugation technologies and services; it set out to create market-leading flexibility to support scientists from academia through to commercial manufacturing.
Products are based on its antibody and protein labelling, nanoparticle, oligonucleotide labelling and phosphate detection enzyme assay technologies.
The facilities expansion marks the next stage in the company’s development and Innova says this is in response to increasing demand for its products and services.
CEO Dr Nick Gee said: “Innova has expanded its laboratory space to accommodate the need for increased and continuous development of new products based on our bioconjugation technology, in addition to the custom services offering which has also grown year on year.”
Innova was shortlisted in the Life Science Innovation category of the Business Weekly Awards last month, overseen by industry specialist sponsors AstraZeneca and MedImmune.